Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$20.9M
+35.1% from 2023
Prescriptions
2,219
$9,414.05 per claim
Patients
867
567 prescribers
Total spending, 2024
$20.9M
$24,085.30 per patient
Medicare prescription drug plans paid $20.9M for Truxima in 2024, for 2,219 prescriptions and refills to 867 patients (up 35.1% from 2023). The average cost per claim was $9,414.05.
New York had the highest Medicare cost for Truxima in 2024: $4.1M for 447 claims, followed by California ($3.2M).
Michael Naarendorp, rheumatology in New York, NY, had the highest Medicare cost for Truxima in 2024: 32 claims costing $456K.
Truxima is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Cephalon,Inc.-T.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Michael Naarendorp New York, NY | Rheumatology | 32 | 18 | $456K |
| Raz Khavari Van Nuys, CA | Rheumatology | 24 | Under 11 | $382K |
| Maria A Scouros Houston, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 291 | 1,309 | 494 | $12.7M |
| 2023 | 390 | 1,580 | 614 | $15.5M |
| 2024 | 567 | 2,219 | 867 | $20.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 49 |
| Under 11 |
| $348K |
| Leslie McCasland Jonesboro, AR | Rheumatology | 18 | Under 11 | $268K |
| Alec S Goldenberg New York, NY | Hematology-Oncology | 36 | Under 11 | $228K |
| Thomas B Sneed Little Rock, AR | Hematology-Oncology | 40 | Under 11 | $211K |
| Gerald Y Ho La Palma, CA | Rheumatology | 15 | Under 11 | $210K |
| Jen Chin Wang Long Beach, NY | Internal Medicine | 39 | Under 11 | $209K |
| Brady P Nelson Peoria, AZ | Physician Assistant | 12 | Under 11 | $200K |
| Kamal Patel Little Rock, AR | Hematology-Oncology | 32 | Under 11 | $196K |
| Ratesh Khillan Brooklyn, NY | Medical Oncology | 14 | Under 11 | $191K |
| Jose F Roldan San Antonio, TX | Rheumatology | 13 | Under 11 | $186K |
| Richards Afonja Clifton, NJ | Hematology-Oncology | 19 | Under 11 | $186K |
| Inmaculada del Rincon San Antonio, TX | Rheumatology | 11 | Under 11 | $184K |
| Gardith Joseph Brooklyn, NY | Hematology-Oncology | 20 | Under 11 | $177K |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 28 | Under 11 | $173K |
| Mariann Harrington Little Rock, AR | Hematology-Oncology | 25 | Under 11 | $171K |
| Dirk C Davidson Crossville, TN | Medical Oncology | 16 | Under 11 | $158K |
| Jasen C CHI Little Rock, AR | Rheumatology | 16 | Under 11 | $147K |
| Balagopalan Nair Little Rock, AR | Hematology-Oncology | 27 | Under 11 | $122K |
| Basma Al Nahlawi San Marcos, CA | Rheumatology | 11 | Under 11 | $120K |
| Ryan E Hall Little Rock, AR | Hematology-Oncology | 20 | Under 11 | $120K |
| Muhammad Saad Hamid Memphis, TN | Hematology-Oncology | 16 | Under 11 | $119K |
| Lawrence A Mendelsohn Little Rock, AR | Hematology-Oncology | 21 | Under 11 | $114K |
| Sejal N Vaidya Silver Spring, MD | Nurse Practitioner | 17 | Under 11 | $113K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Cephalon,Inc.-T TEVA | 2,220 | $20.9M |